Mark Lampert, AB, MBA
Mark Lampert is the founder of BVF Partners L.P., a San Francisco-based, private investment firm established in 1994. Mr Lampert has engaged in ventures relating to the biotechnology industry since 1984. Most recently, Mr Lampert was a Vice President at the investment banking firm Oppenheimer & Co. in New York, where he created novel biotechnology investment vehicles. Prior to joining Oppenheimer & Co., he founded Biotechnology Royalty Corp., which pooled biotechnology patent royalties owned by universities. From 1987 to 1990, Mr Lampert headed business development for Cambridge NeuroScience, a public biotechnology company. From 1984 to 1986, Mr Lampert served as Assistant to the President of the NutraSweet Company, a subsidiary of G.D. Searle & Co., and he also worked for the Boston Consulting Group. Mr Lampert is a Director of Athersys, Inc., AVMAX and Mendel Biotechnology. He holds an AB Degree in chemistry from Harvard College and an MBA Degree from Harvard Business School.